In a statement from Razi Institute's Public Relations department, Dr. Morteza Akbarian directorate in charge and advisor to the Director General of Razi Vaccine and Serum Research Institute, emphasized the institute's crucial role in therapeutic serum production. He noted that this initiative was established in Iran by the late Dr. Latifi within the institute’s venomous animal department. According to numerous international specialists, the antivenoms produced by Razi are regarded as some of the highest quality products available globally.
Razi Vaccine & Serum Research Institute is setting its sights on obtaining a World Health Organization (WHO) collaborating laboratory license to enhance research in the field of venom and antivenom, according to Dr. Soheila Moradi Bidhendi, the institute's Deputy for Research and Technology. This initiative aims to expand international collaborations dedicated to preserving human health.
Dr. Najmeh Motamed, The executive secretary of the International Online Conference on Venomous Animals and Antivenom has highlighted the profound impact of Razi Vaccine & Serum Research Institute's antivenoms, which have saved countless lives across Iran and the Middle East. This year, RVSRI unveiled a new antivenom specifically developed for venomous snakes found in Sistan and Baluchestan Province.